Search results for "Neoplastic"

showing 10 items of 2901 documents

Biomaterial-Induced Sarcoma

2000

In the study of carcinogenesis most interest has focused on carcinomas, as they represent the majority of human cancers. The recognition of the adenoma-carcinoma sequence both in humans and in animal experimental models has given the field of basic oncology the opportunity to elucidate individual mechanisms in the multistep development of carcinoma. The relative scarcity of human sarcomas coupled with the lack of adequate animal models has hampered understanding of the molecular genetic steps involved. We present an experimental model in the rat in which a high incidence of malignant mesenchymal tumors arise around a subcutaneously implanted biomaterial. Nine commercially available biomater…

Pathologymedicine.medical_specialtyMesenchymal stem cellBiologyMalignancymedicine.diseasemedicine.disease_causePathology and Forensic MedicineTumor progressionmedicineCarcinomaImmunohistochemistrySarcomaCarcinogenesisPreneoplastic ChangeThe American Journal of Pathology
researchProduct

Current understanding of somatic stem cells in leiomyoma formation.

2014

Objective To provide a detailed summary of current scientific knowledge of somatic stem cells (SSCs) in murine and human myometrium and their putative implication in leiomyoma formation, as well as to establish new therapeutic options. Design Pubmed and Scholar One manuscripts were used to identify the most relevant studies on SSCs and their implications in human myometrium and leiomyomas. Setting University research laboratory–affiliated infertility clinic. Patient(s) Not applicable. Intervention(s) Not applicable. Main Outcome Measure(s) Not applicable. Result(s) Despite numerous publications on SSCs, it was not until 2007 that scientific evidence based on the use of 5-bromo-2′-deoxyuridi…

Pathologymedicine.medical_specialtyMyocytes Smooth MuscleBioinformaticsBenign tumorSide populationMedicineHumansEpigeneticsSide-Population CellsUterine leiomyomaLeiomyomabusiness.industryMyometriumObstetrics and Gynecologymedicine.diseaseLeiomyomaCell Transformation NeoplasticReproductive MedicineUterine NeoplasmsMyometriumNeoplastic Stem CellsFemalebusinessAdult stem cellHormoneFertility and sterility
researchProduct

Tissue microarray construction for salivary gland tumors study

2012

Objective: To describe and discuss the design, building and usefulness of tissue microarray (TMA) blocks for the study of salivary gland tumors (SGTs). Study Design: Two hundred thirty-eight formalin-fixed, paraffin-embedded SGTs were arranged in blocks of TMA using a manual tissue arrayer. Three representative cores of 1.0, 2.0 or 3.0mm were taken from each original block and their characteristics were analyzed and described. Results: It was created 12 TMA blocks that presented highly representative neoplastic cylinders. However, those neoplasias rich in cystic spaces such as mucoepidermoid carcinoma and Warthin tumor presented more difficulties to be sampled, as the neoplastic tissue avai…

Pathologymedicine.medical_specialtyOdontologíaTissue Array AnalysisBiologyMucoepidermoid carcinomaTissue damagemedicineHumansNeoplastic tissueGeneral DentistryOral Medicine and PathologyTissue microarraySalivary glandWarthin Tumor:CIENCIAS MÉDICAS [UNESCO]Salivary Gland Neoplasmsmedicine.diseaseCiencias de la saludmedicine.anatomical_structureOtorhinolaryngologyTissue Array AnalysisUNESCO::CIENCIAS MÉDICASResearch-ArticleSurgeryMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Proteomic patterns of cultured breast cancer cells and epithelial mammary cells.

2002

: Breast cancer is one of the leading causes of death from cancer among women in western countries. The different types of breast cancer are grouped into invasive and noninvasive forms. Among the invasive types, ductal infiltrating carcinoma (DIC) is the most common and aggressive form. Using an in vitro model consisting of a DIC-derived cell line (8701-BC) and a nontumoral mammary epithelial cell line (HB2), we used the proteomics approach to search for homology and differences in protein expression patterns between tumoral and nontumoral phenotypes. Within an analysis window comprising 1,750 discernible spots we have currently catalogued 140 protein spots of potential interest. Fifty-eigh…

Pathologymedicine.medical_specialtyProteomeBreast NeoplasmsBiologyProteomicsGeneral Biochemistry Genetics and Molecular Biologyductal infiltrating carcinomaBreast cancerbreast cancerHistory and Philosophy of ScienceGene expressionTumor Cells Culturedmedicineproteomics; breast cancer; ductal infiltrating carcinomaHumansBreastSettore BIO/06 - Anatomia Comparata E CitologiaproteomicGeneral NeuroscienceEpithelial Cellsmedicine.diseasePhenotypeCell cultureProteomeCancer cellCancer researchNeoplastic cell
researchProduct

C-erbB-2-oncogene expression in breast carcinoma: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters

1992

The c-erbB-2 mRNA was detected by the S1 nuclease protection assay and Northern blotting in breast cancer tissues. In contrast to the Northern blot analysis which has been used in all recent publications concerning c-erbB-2 expression on the level of RNA, the S1-nuclease protection assay has distinct advantages with respect to sensitivity, reproducibility, and handling of radioactive probes. We compared the expression of c-erbB-2 in 120 breast carcinomas which were operated in the years 1989-1990 on the level of the mRNA (S1 nuclease protection assay) and the protein (immunohistochemistry), respectively. In general, results obtained with both methods were in good agreement. Only minor diffe…

Pathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsBiologyGene Expression Regulation EnzymologicImmunoenzyme TechniquesBreast cancerProto-Oncogene ProteinsGene expressionmedicineHumansRNA NeoplasmNorthern blotskin and connective tissue diseasesLymph nodeOncogeneSingle-Strand Specific DNA and RNA EndonucleasesObstetrics and GynecologyBlotting Northernmedicine.diseaseSurvival AnalysisGene Expression Regulation NeoplasticBlotmedicine.anatomical_structureOncologyCancer researchImmunohistochemistryFemaleBreast carcinomaGynecologic Oncology
researchProduct

Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors

2010

Objectives: The present study was undertaken to assess and compare the immunohistochemical expression of Bcl-2 in selected benign and malignant salivary gland tumors. Study Design: A total of 50 cases of buffered formalin-fixed, paraffin embedded tissues of previously diagnosed cases of benign and malignant salivary gland tumors from the archives of Department of Oral and Maxillofacial Pathology and Microbiology, SDM College of Dental Sciences and Hospital, Dharwad, India, were taken for the study. The immunohistochemical staining procedure was performed using monoclonal anti Bcl-2 antibody, as directed by the manufacturer. Results: Thirty six cases (72%) out of 50 cases showed a positive e…

Pathologymedicine.medical_specialtySalivary glandbusiness.industryCanalicular adenomamedicine.diseaseSalivary Gland Neoplasms:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryStainingGene Expression Regulation Neoplasticmedicine.anatomical_structureOtorhinolaryngologyProto-Oncogene Proteins c-bcl-2Oral and maxillofacial pathologyMonoclonalUNESCO::CIENCIAS MÉDICASmedicineImmunohistochemistryHumansSurgerybusinessGeneral DentistrySurvival rateLymph node
researchProduct

In Vitro Identification and Characterization of CD133pos Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines

2008

BackgroundRecent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown.Methodology/principal findingsATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64+/-9% and 57+/-12%, respectively). These …

Pathologymedicine.medical_specialtySciencemedicine.medical_treatmentThyroid Nuclear Factor 1Cell Culture TechniquesAntineoplastic AgentsCell SeparationStem cell markerDiabetes and Endocrinology/ThyroidSettore MED/13 - EndocrinologiaAntigens CDThyroid peroxidaseCancer stem cellCell Line TumorBiomarkers TumormedicineHumansANAPLASTIC THYROID CARCINOMA CANCER STEM CELLS CD133AC133 AntigenThyroid NeoplasmsGenetics and Genomics/Cancer GeneticsThyroid cancerTumor Stem Cell AssayCell ProliferationGlycoproteinsOncology/Head and Neck CancersMultidisciplinarybiologyCell growthQCarcinomaRNuclear ProteinsTumor Stem Cell Assaymedicine.diseaseFibronectinsembryonic structuresNeoplastic Stem CellsCancer researchbiology.proteinMedicineThyroglobulinStem cellPeptidesTranscription FactorsResearch ArticlePLoS ONE
researchProduct

Prognostic significance of c-erB-2 mRNA in ovarian carcinoma.

1996

The oncogene specific mRNA of c-erbB-2 was detected by the S1 nuclease protection assay in 95 ovarian cancer specimens. In 79 primary carcinomas, we found 16 (20%) with strong expression, 13 (17%) with weak expression, 4 (5%) with very weak expression, and 46 (58%) with no expression. In 3 of 16 recurrencies (19%) a strong expression of c-erbB-2 mRNA was detected, in 2 (12%) weak expression was detected, and in 11 (69%) no expression of c-erbB-2 mRNA was detected. Kaplan-Meier analysis revealed no significant association between strong expression of c-erbB-2 mRNA and survival of the 79 patients with primary cancer. However, in the subgroup of patients with FIGO (International Federation of …

Pathologymedicine.medical_specialtySerous carcinomaReceptor ErbB-2OvaryAndrologyPredictive Value of TestsOvarian carcinomamedicineCarcinomaHumansRNA MessengerRNA NeoplasmStage (cooking)neoplasmsNeoplasm StagingOvarian NeoplasmsMessenger RNAOncogenebusiness.industryObstetrics and Gynecologymedicine.diseasePrognosisSurvival AnalysisUp-RegulationGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyFemaleOvarian cancerbusinessGynecologic oncology
researchProduct

Identification of progenitor cancer stem cell in lentigo maligna melanoma.

2008

:  The potential role of stem cells in neoplasia has aroused considerable interest over the past few years. A number of known biologic characteristics of melanomas support the theory that they may originate in a mutated stem cell. Melanocytic stem cell markers have been described recently. Moreover, the CD133 cells that show surface markers for CD34 are stem cells primitive. These stem cells are capable of differentiating into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. The identification of cancer stem/initiating cells with a crucial role in tumor formation may open up new pharmacologic perspectives. The purpose of this study is to detect the expression of …

Pathologymedicine.medical_specialtySkin NeoplasmsCD34Antigens CD34DermatologyBiologyStem cell markerHutchinson's Melanotic FreckleCancer stem cellAntigens CDMelanoblastmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansAC133 AntigenLentigo maligna melanomaGlycoproteinsMelanomaGeneral Medicinemedicine.diseasecancer stem cell lentigo maligna melanomaNeoplastic Stem CellsMelanocytesStem cellPeptidesHair FollicleBiomarkersAdult stem cell
researchProduct

Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management

2013

Dermatofibrosarcoma protuberans (DFSP) is a rare superficial tumor characterized by high rates of local recurrence and low risk of metastasis. DFSP occurs most commonly on the trunk and proximal extremities, affects all races, and often develops between the second and fifth decade of life. The tumor grows slowly, typically over years. Histologically, several variants of DFSP have been described and should be well characterized to avoid misdiagnosis with other tumors. These include pigmented (Bednar tumor), myxoid, myoid, granular cell, sclerotic, atrophic DFSP, giant cell fibroblastoma, and DFSP with fibrosarcomatous areas. Of all these variants, only the DFSP with fibrosarcomatous areas is…

Pathologymedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentAntineoplastic AgentsPiperazinesTranslocation GeneticPathology and Forensic MedicineMetastasismedicineDermatofibrosarcoma protuberansHumansbusiness.industryStandard treatmentWide local excisionDermatofibrosarcomaImatinibGiant-cell fibroblastomaMohs Surgerymedicine.diseaseCombined Modality TherapyDermatologyPyrimidinesImatinib mesylateBenzamidesImatinib MesylateNeoplasm Recurrence LocalDifferential diagnosisbusinessmedicine.drugSeminars in Diagnostic Pathology
researchProduct